1. Cryoprotectant Use

Propylene glycol (PG) is a widely used cryoprotective agent (CPA) that protects cells and tissues from damage during freezing and thawing. It functions by lowering the freezing point of a solution and reducing ice crystal formation, which are primary causes of cryoinjury. PG is categorized as a penetrating cryoprotectant, meaning it can cross cell membranes and protect intracellular components.

2. Applications

PG finds application in various fields, including:

1. Cryopreservation of cells: Red blood cells, stem cells, and various cell lines.
2. Tissue preservation: Skin grafts, heart valves, and other tissues.
3. Organ preservation: Research is ongoing to improve organ cryopreservation protocols using PG and other CPAs.
4. Food industry: As a humectant and antifreeze agent.
5. Pharmaceutical industry: As a solvent and excipient in various formulations.

For instance, PG is a key component in cryopreservation media for hematopoietic stem cell transplantation.

3. Mechanism of Action

PG, like other penetrating CPAs, exerts its protective effects through multiple mechanisms:

1. Colligative properties: Reduces the freezing point of the solution, slowing ice formation and minimizing the time cells are exposed to damaging temperatures.
2. Water replacement: PG can replace water molecules in the hydration shell of proteins and other macromolecules, stabilizing their structure during dehydration and freezing.
3. Vitrification: At high concentrations, PG can contribute to vitrification, a process where the solution transitions into a glass-like amorphous solid without ice crystal formation.
4. Reduced osmotic stress: The controlled addition of PG helps mitigate osmotic stress during the addition and removal stages of cryopreservation.

4. Concentration and Protocol

The optimal concentration of PG varies depending on the cell type and specific application. Typical concentrations range from 5% to 20% (v/v). A typical protocol involves stepwise addition of PG to the cell suspension, followed by slow cooling and rapid thawing. Example:

1. Prepare a cell suspension in an appropriate medium.
2. Slowly add PG to the cell suspension to the desired final concentration (e.g., 10% v/v) over several minutes, keeping the solution on ice.
3. Transfer the cell suspension to cryovials.
4. Cool the cryovials at a controlled rate of 1°C/minute to -80°C or lower using a controlled-rate freezer or a programmable freezer.
5. Transfer the cryovials to liquid nitrogen for long-term storage.
6. For thawing, rapidly warm the cryovial in a 37°C water bath.
7. Dilute and wash the cell suspension to remove PG.

5. Safety and Handling

PG is generally considered safe for handling with appropriate precautions. However, it is irritating to the skin and eyes. Always wear gloves, eye protection, and a lab coat when handling PG. Work in a well-ventilated area to avoid inhaling vapors. Follow established laboratory safety guidelines.

6. Advantages

Compared to other CPAs like DMSO, PG is generally less toxic at similar concentrations, making it suitable for sensitive cells. It also exhibits lower viscosity, facilitating easier handling and mixing. Its lower cost is another advantage.

7. Disadvantages

PG's cryoprotective efficacy can be lower than DMSO for certain cell types, requiring higher concentrations or modified protocols. It can also induce osmotic stress if added or removed too quickly.

8. Compatibility

PG is compatible with various cell types, including red blood cells, stem cells, and many cell lines. Its compatibility with specific cell types should be determined experimentally. For example, it has been successfully used in cryopreservation of umbilical cord blood hematopoietic stem cells and mesenchymal stem cells.

9. Toxicity Profile

PG exhibits relatively low toxicity compared to some other CPAs. However, high concentrations or prolonged exposure can be detrimental. Toxicity can manifest as reduced cell viability, altered metabolic activity, or DNA damage. The toxicity profile is influenced by factors like concentration, exposure time, cell type, and temperature.

10. Solubility

PG is highly soluble in water and other polar solvents, making it easy to prepare solutions for cryopreservation.

11. Storage Conditions

Store PG in a cool, dry place, away from direct sunlight and heat. Follow the manufacturer's recommendations for storage temperature and shelf life.

12. Interaction with Other CPAs

PG can be used in combination with other CPAs, such as DMSO or glycerol, to enhance cryoprotection. The optimal combination and concentrations depend on the specific application. For instance, a combination of PG and DMSO has been explored in cryopreserving certain tissues.

13. Regulatory Status

PG is generally recognized as safe (GRAS) by the FDA for certain applications, including food and pharmaceutical uses. However, specific regulatory requirements may apply depending on the intended use, particularly in clinical applications.

14. Environmental Impact

PG is biodegradable and considered to have a relatively low environmental impact. However, appropriate disposal methods should be followed to minimize any potential environmental effects.

15. Historical Context

PG has been used as a cryoprotectant for several decades. Early research demonstrated its effectiveness in preserving red blood cells, paving the way for its broader application in other areas of cryobiology.

16. Alternative Cryoprotectants

1. DMSO: Higher cryoprotective efficacy but higher toxicity.
2. Glycerol: Lower toxicity but lower efficacy.
3. Trehalose: A non-toxic disaccharide used for certain applications.

The choice of cryoprotectant depends on factors like cell type, desired outcome, and cost considerations.

17. Physical Properties

PG is a clear, colorless, viscous liquid with a slightly sweet taste. It has a low freezing point and is miscible with water.

18. Cost-Effectiveness

PG is generally more cost-effective than other CPAs like DMSO, making it a preferred choice in large-scale applications or where budget is a constraint.

19. Known Issues

Potential issues include variability in quality between different suppliers and potential for contamination if not stored properly. Some cell types may be sensitive to even low concentrations of PG.

20. Handling Instructions

Prepare PG solutions using sterile techniques. Filter sterilize if necessary. Add PG slowly to the cell suspension to avoid osmotic shock. Use appropriate personal protective equipment during handling. Follow established laboratory safety guidelines for handling and disposal.

21. Conclusion

Propylene glycol is a valuable cryoprotective agent with broad applications in various fields. Its relatively low toxicity, ease of handling, and cost-effectiveness make it a preferred choice in many cryopreservation protocols. Understanding its mechanism of action, advantages, and limitations is crucial for optimizing cryopreservation procedures and achieving successful outcomes.

References

1. Fahy, G. M., Wowk, B., Wu, J., Paynter, S. J., & MacFarlane, D. R. (2004). Cryopreservation of complex systems: Some fundamentals and recent advances. Cryobiology, 48(2), 157-199.

2. Maddison, K., & Day, J. G. (2015). Cryopreservation protocols for algae. In Algal culturing techniques (pp. 663-679). Academic Press.

3. Elliott, J. A. W., Elliott, T., & McGann, L. E. (2005). Cryoprotectant toxicity and cryoinjury: Mechanisms of cell damage. Bioscience and Bioengineering of Titanium Materials, 9(4), 407-413.

4. Woods, E. J., Hughes, C. M., Petersen, E., & Edwards, E. B. (2011). Sources of hematopoietic stem cells for transplantation. British journal of haematology, 154(5), 578-591.

5. Shu, Z., Yong, K. W., Yang, Y., Huang, M., & Yu, X. J. (2014). Concise review: mesenchymal stem cells transplantation therapy: a promising therapeutic strategy for stroke and other neurological diseases. Stem Cells Translational Medicine, 3(7), 815-821.

6. Lovelock, J. E. (1954). The protective action of neutral solutes against haemolysis by freezing and thawing. Biochem. J, 56, 265-270.

7. Pegg, D. E. (2007). Principles of cryopreservation. Methods in molecular biology, 384, 39-57.

8. Best, B. P. (2015). Cryoprotectant toxicity: Facts and fiction. Cryobiology, 71(1), 122-126.

9. Fuller, B. J., Lane, N., & Benson, E. E. (Eds.). (2004). Life in the frozen state. CRC press.

10. Hubel, A., Spindler, R., & Skladal, P. (2007). Vitrification: State of the art. Cryo Letters, 28(3), 121-136.

11. Baust, J. M., Van Buskirk, R. G., & Baust, J. G. (2002). Cell viability improves following inhibition of cryopreservation-induced apoptosis. In vitro cellular & developmental biology. Animal, 38(3-4), 147-150.

12. Kheirikhah, M., & Ibrahim, S. (2012). Influence of cryoprotective agents and freezing methods on viability, DNA fragmentation, and ultrastructure of cryopreserved ram spermatozoa. Journal of Andrology, 30(5), 330-339.

13. Rowley, S. D., Davenport, J. G., Garewal, H. S., Atkinson, K., & Goldman, S. (1998). Plasma and red cell removal by column filtration during hematopoietic stem cell processing. Transfusion, 38(9), 834-839.

14. Fowler, C. J., Toner, M., & Hubel, A. (2012). Advances in cryopreservation of tissues and organs: challenges and opportunities. International journal of surgery, 10(6), 295-304.